Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GNAQ targeted dsRNA compositions and methods for inhibiting expression

GNAQ targeted dsRNA compositions and methods for inhibiting expression

US Patent 12031133 · Granted Jul 9, 2024

Estimated economic value: $382,980,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Crispr/CAS-related methods and compositions for treating primary open angle glau2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLK2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
Compositions and methods for inhibiting expression of transthyretin2025
IRAK4 degraders and uses thereof2024
Phenothiazine derivatives and uses thereof2024
Organic compositions to treat HSF1-related diseases2024
Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof2024
SERPINA1 iRNA compositions and methods of use thereof2024